+31 (0)50 211 03 48
Prof. M. Oudkerk, MD, PhD
Prof. Oudkerk is responsible for Research & Development in iDNA.
Many of the current and new guidelines in CT screening for lung cancer and cardiovascular diseases are derived from his original work. His vision on the future of imaging and healthcare has been recognized with many international awards and invitations to lecture on (inter-)national platforms.
With an H-Index (a measure of research and citation impact) of 70, prof. Oudkerk is a true leading expert in the field of early detection of lung cancer and cardiovascular diseases. As Principal Investigator of the NELSON study, he paved the way for the implementation of lung cancer screening in Europe.
Prof. Oudkerk is a radiologist by training and completed his medical training in Leiden, the Netherlands. He has been professor in Radiology for more than 20 years and published more than 550 scientific articles.
+31 (0)6 21 55 19 99
Erik Jippes, PhD, MBA
Erik Jippes is responsible for the day-to-day operation of iDNA.
Erik’s background working in a medical academic environment, and with medical imaging in particular, enables him to understand and act on the complexities in hospital environments. This is of great importance for implementing lung cancer screening programmes.
Erik has a Master of Business Administration and holds a PhD in social networks and innovation processes in healthcare. He worked for more than 14 years at a University Medical Center and was responsible for several large public–private partnerships, pre- and post-award project management for funding support (H2020, national and regional grants), and charity fundraising.
He was manager of several large-scale population-based early detection and screening trials in lung cancer and cardiovascular diseases.
In his spare time Erik likes to travel with his wife and three children, and he loves to play beach volleyball.
+31 (0)6 24 21 71 13
Evgeni Dvortsin, MSc
Evgeni Dvortsin is a health economist and healthcare entrepreneur, responsible for leading the development and execution of the long-term strategies of iDNA.
His background as a founder of Asc Academics — a globally operating health economics and market access consultancy — provides an excellent knowledge foundation in cost-benefit analyses in healthcare. This is of the utmost importance for the implementation of lung cancer early detection and screening programs. In addition, Evgeni co-founded the General Practitioners Research Institute (GPRI), which aims to improve the lives of patients by facilitating participation in real world evidence generation studies.
Evgeni has a background as a pharmacist and pharmaceutical scientist at the University of Groningen, and, in his rare moments of spare time, he enjoys everything related to basketball.
+31 (0)6 42 29 99 19
Jie Hui Chen, MBA
Jie Hui Chen is responsible for the strategic partnerships and relations with Asia. She is also responsible for the day-to-day operation for iDNA Asia.
Jie Hui is an entrepreneur who has more than 15 years of experience in bridging Asian and Dutch companies. She studied Asian Business Studies and obtained an MBA certificate from national Sun Yat Sen University in Taiwan. She is an expert in Chinese language and culture and has an extensive network within Asia. Since 2016, Jie Hui has been the liaison manager between hospitals in China and the Netherlands for several large-scale population-based early detection and screening studies in lung cancer and cardiovascular diseases.
Moreover, she has a personal motivation; her grandmother in China passed away from lung cancer. This inspires her to give her best every day for iDNA.
Jie Hui likes to travel and explore new cultures with her husband and two children.